Received May 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | — | — |
injected with a CAPVAXIVE injection a few weeks ago, that she had a large red area that took 1 to 2 days to go away; fever; Vaccination site warmth; malaise; This spontaneous report was received from a pharmacist and refers to a female patient of unknown age. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 2025 (also report as a few weeks ago), the patient was vaccinated with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE), (lot # and expiration date were not reported) for prophylaxis. On 2025, the patient had a large red area that took 1 to 2 days to go away. It also had fever and was warm, having a lot of warmth and fever. She had also a day or so of general malaise, after the injection. She recovered from the events (also reported as from the injection) on an unspecified date in 2025. No hospitalization or prolonged treatment was needed. The causal relationship between the events and Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) was not provided.